Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a methodology for dose assessment and estimate of amount of NORM residues disposable in a conventional landfill.
Venoso G, Nuccetelli C, Leonardi F, Di Carlo C, Trotti F, Ugolini R, Mrdakovic Popic J, Trevisi R, Caplin H, Pérez-Sánchez D, Février L, Urso L. Venoso G, et al. Among authors: urso l. J Environ Radioact. 2024 Dec;280:107564. doi: 10.1016/j.jenvrad.2024.107564. Epub 2024 Nov 9. J Environ Radioact. 2024. PMID: 39522435 Free article.
Is There a Role for FAPI PET in Urological Cancers?
Ortolan N, Urso L, Zamberlan I, Filippi L, Buffi NM, Cittanti C, Uccelli L, Bartolomei M, Evangelista L. Ortolan N, et al. Among authors: urso l. Mol Diagn Ther. 2024 Nov;28(6):721-725. doi: 10.1007/s40291-024-00735-9. Epub 2024 Aug 24. Mol Diagn Ther. 2024. PMID: 39181989 Free PMC article. Review.
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer.
Urso L, Cittanti C, Manco L, Ortolan N, Borgia F, Malorgio A, Scribano G, Mastella E, Guidoboni M, Stefanelli A, Turra A, Bartolomei M. Urso L, et al. Diagnostics (Basel). 2024 Jun 15;14(12):1264. doi: 10.3390/diagnostics14121264. Diagnostics (Basel). 2024. PMID: 38928679 Free PMC article.
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study).
Bauckneht M, Lanfranchi F, Albano D, Triggiani L, Linguanti F, Urso L, Mazzola R, Rizzo A, D'Angelo E, Dondi F, Mataj E, Pedersoli G, Abenavoli EM, Vaggelli L, Detti B, Ortolan N, Malorgio A, Guarneri A, Garrou F, Fiorini M, Grimaldi S, Ghedini P, Iorio GC, Iudicello A, Rovera G, Fornarini G, Bongiovanni D, Marcenaro M, Pazienza FM, Timon G, Salgarello M, Racca M, Bartolomei M, Panareo S, Ricardi U, Bertagna F, Alongi F, Barra S, Morbelli S, Sambuceti G, Belgioia L. Bauckneht M, et al. Among authors: urso l. J Nucl Med. 2024 Aug 1;65(8):1202-1209. doi: 10.2967/jnumed.124.267586. J Nucl Med. 2024. PMID: 38906557 Free PMC article.
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer.
Evangelista L, Zattoni F, Burei M, Bertin D, Borsatti E, Baresic T, Farsad M, Trenti E, Bartolomei M, Panareo S, Urso L, Trifirò G, Brugola E, Chierichetti F, Donner D, Setti L, Gallan M, Del Bianco P, Magni G, De Salvo GL, Novara G; Study Group Coinvestigators. Evangelista L, et al. Among authors: urso l. J Nucl Med. 2024 Jul 1;65(7):1013-1020. doi: 10.2967/jnumed.123.267355. J Nucl Med. 2024. PMID: 38844361 Clinical Trial.
270 results